Table 5.
Percentagea of overall liver graft non-use due to donor characteristics in 2010
| Characteristic | % of non-useb | (95% CI) |
|---|---|---|
| Age | ||
| < 30 | [Ref] | |
| 30–39 | 3.7 | (2.3–5.1) |
| 40–49 | 11.6 | (9.7–13.6) |
| 50–59 | 15.3 | (13.2–17.2) |
| ≥ 60 | 7.6 | (6.2–9.0) |
| Female | 3.0 | (1.5–4.5) |
| Race | ||
| White | 16.8 | (13.3–20.3) |
| Black | [Ref] | |
| Other | 7.8 | (6.7–8.8) |
| Body mass index | ||
| < 18.5 | 0.3 | (0.1–0.6) |
| 18.5–24+ | [Ref] | |
| 25–29+ | 2.7 | (1.3–4.1) |
| 30–39+ | 10.7 | (9.4–11.9) |
| ≥ 40 | 4.2 | (3.7–4.7) |
| Diabetes | 1.0 | (0.2–1.7) |
| DCD | 28.4 | (27.0–29.8) |
| Cause of death | ||
| Trauma | [Ref] | |
| CVA | 3.5 | (1.5–5.4) |
| Alcohol use | 10.9 | (10.0–11.9) |
| Inotrope support | 2.4 | (0.5–4.2) |
| ALT, U/L | ||
| ≤ 40 | [Ref] | |
| 41–200 | 11.0 | (9.6–12.4) |
| 201–400 | 2.9 | (2.4–3.3) |
| > 400 | 6.0 | (5.5–6.4) |
| Bilirubin, mg/dL | ||
| ≤ 1.2 | [Ref] | |
| 1.3–2.5 | 4.3 | (3.5–5.1) |
| 2.6–5 | 2.9 | (2.5–3.3) |
| > 5 | 2.6 | (2.3–2.9) |
| Hepatitis C antibody | 2.3 | (2.0–2.7) |
Abbreviations: CI, confidence interval; DCD, donation after cardiac death; CVA, cerebrovascular accident; ALT, alanine aminotransferase.
a
Calculated as the population attributable risk proportion, based on the multivariate logistic regression model.
b
Percentages do not sum to 100% because population attributable risk proportions are not independent.